Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-15 Sale | 2025-08-18 8:15 pm | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 25,500 | $2.7286 | $69,579 | 382,221 (Direct) | View |
| 2024-07-22 Purchase | 2024-07-24 4:27 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 8,333,333 | $12 | $99,999,996 | 1,288,519 (Indirect) | View |
| 2024-07-22 Purchase | 2024-07-24 4:15 pm | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 833,333 | $12 | $9,999,996 | 1,643,741 (Indirect) | View |
| 2024-07-22 Purchase | 2024-07-22 8:26 pm | Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 416,666 | $12 | $4,999,992 | 2,398,324 (Direct) | View |
| 2024-07-22 Purchase | 2024-07-22 8:25 pm | Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner | 2,083,332 | $12 | $24,999,984 | 5,117,845 (Indirect Direct) | View |
| 2024-07-22 Purchase | 2024-07-22 8:22 pm | Artiva Biotherapeutics Inc. | ARTV | Huh Yong-Jun Director | 2,083,332 | $12 | $24,999,984 | 1,810,945 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 4,472 | $2.13 | 382,221 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 4,472 | $2.75 | 382,221 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 745 | $2.13 | 40,966 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 1,639 | $2.75 | 40,966 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer | 1,341 | $2.13 | 102,846 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer | 5,813 | $2.75 | 102,846 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off | 1,937 | $2.13 | 151,103 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off | 6,409 | $2.75 | 151,103 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 1,341 | $2.13 | 80,082 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 3,577 | $2.75 | 80,082 (Direct) | View |
| 2025-06-24 Option Award | 2025-06-26 4:51 pm | N/A 2035-06-23 | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 13,750 | $0 | 13,750 (Indirect) | View |
| 2025-06-24 Option Award | 2025-06-26 4:30 pm | N/A 2035-06-23 | Artiva Biotherapeutics Inc. | ARTV | MOORE ALISON Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2025-06-24 Option Award | 2025-06-26 4:30 pm | N/A 2035-06-23 | Artiva Biotherapeutics Inc. | ARTV | Baker Daniel G. Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2025-06-24 Option Award | 2025-06-26 4:30 pm | N/A 2035-06-23 | Artiva Biotherapeutics Inc. | ARTV | HOUGEN ELIZABETH L Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2025-06-24 Option Award | 2025-06-26 4:30 pm | N/A 2035-06-23 | Artiva Biotherapeutics Inc. | ARTV | Stoppel Laura Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2025-06-24 Option Award | 2025-06-26 4:30 pm | N/A 2035-06-23 | Artiva Biotherapeutics Inc. | ARTV | Miralles Gines Diego Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2025-06-24 Option Award | 2025-06-26 4:30 pm | N/A 2035-06-23 | Artiva Biotherapeutics Inc. | ARTV | DANIELS BRIAN Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2025-04-08 Option Award | 2025-04-25 5:07 pm | N/A 2035-04-07 | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:35 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 200,000 | $0 | 416,665 (Direct) | View |
| 2025-02-26 Option Award | 2025-02-28 5:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 33,350 | $0 | 43,350 (Direct) | View |
| 2025-02-26 Option Award | 2025-02-28 5:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Graef Thorsten Chief Medical Officer | 60,000 | $0 | 80,000 (Direct) | View |
| 2025-02-26 Option Award | 2025-02-28 5:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 60,000 | $0 | 85,000 (Direct) | View |
| 2025-02-26 Option Award | 2025-02-28 5:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer | 60,000 | $0 | 110,000 (Direct) | View |
| 2025-02-26 Option Award | 2025-02-28 5:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off | 86,650 | $0 | 159,449 (Direct) | View |
| 2025-01-28 Option Award | 2025-01-29 4:33 pm | N/A 2035-01-27 | Artiva Biotherapeutics Inc. | ARTV | Baker Daniel G. Director | 27,500 | $0 | 27,500 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-22 8:18 pm | N/A 2034-10-20 | Artiva Biotherapeutics Inc. | ARTV | MOORE ALISON Director | 27,500 | $0 | 27,500 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-13 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-13 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Graef Thorsten Chief Medical Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-13 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-13 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-13 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off | 50,000 | $0 | 72,799 (Direct) | View |
| 2024-07-22 Conversion | 2024-07-24 4:27 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,048,244 | $0 | 1,288,519 (Indirect) | View |
| 2024-07-22 Other | 2024-07-24 4:27 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 461,687 | $10.2 | 1,288,519 (Indirect) | View |
| 2024-07-22 Conversion | 2024-07-24 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 2,116,568 | $0 | 1,643,741 (Indirect) | View |
| 2024-07-22 Other | 2024-07-24 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 461,687 | $10.2 | 1,643,741 (Indirect) | View |
| 2024-07-22 Conversion | 2024-07-22 8:28 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 145,089 | $0 | 243,127 (Direct) | View |
| 2024-07-22 Other | 2024-07-22 8:28 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 49,019 | $10.2 | 243,127 (Direct) | View |
| 2024-07-22 Other | 2024-07-22 8:26 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 461,687 | $0 | 2,398,324 (Direct) | View |
| 2024-07-22 Conversion | 2024-07-22 8:26 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 1,058,284 | $0 | 2,398,324 (Direct) | View |
| 2024-07-22 Conversion | 2024-07-22 8:25 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner | 1,352,252 | $0 | 5,117,845 (Direct) | View |
| 2024-07-22 Other | 2024-07-22 8:25 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner | 550,433 | $10.2 | 5,117,845 (Direct) | View |
| 2024-07-22 Conversion | 2024-07-22 8:22 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Huh Yong-Jun Director | 1,352,252 | $0 | 1,810,945 (Indirect) | View |
| 2024-07-22 Other | 2024-07-22 8:22 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Huh Yong-Jun Director | 550,433 | $10.2 | 1,810,945 (Indirect) | View |
| 2024-07-18 Option Award | 2024-07-22 8:18 pm | N/A 2034-07-17 | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 572,716 | $0 | 572,716 (Direct) | View |
Ownership | 2024-07-18 8:14 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 0 | $0 | 1,058,284 (Direct) | View |
Ownership | 2024-07-18 8:08 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 1,058,282 (Indirect) | View |
Ownership | 2024-07-18 8:06 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 0 | $0 | 1,058,284 (Indirect) | View |
Ownership | 2024-07-18 8:06 pm | 2024-05-01 2034-01-23 | Artiva Biotherapeutics Inc. | ARTV | Miralles Gines Diego Director | 0 | $0 | 25,990 (Direct) | View |